BONESUPPORT AB

BONESUPPORT AB is a Scandinavian orthobiologics company founded in 2000, headquartered in Sweden. The company's slogan, "Restoring health to improve the quality of life for patients with bone disorders," reflects its core mission. BONESUPPORT AB specializes in developing and marketing CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products. These products have proven efficacy in healing defects by remodeling to host bone within six to twelve months. The company's focus on addressing fractures and bone voids caused by trauma, infection, disease, or related surgery showcases its commitment to meeting critical medical needs. Notably, BONESUPPORT AB secured a kr378.00M Post-IPO Equity investment on 26 May 2020. This substantial investment signifies confidence in the company's potential and sets the stage for further growth and innovation in the Biotechnology, Health Care, and Manufacturing industries.